Stay updated on Daratumumab Combo in Resistant Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in Resistant Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page revision updated to v3.3.3 and related-topic links such as HHS Vulnerability Disclosure, Multiple Myeloma, and MedlinePlus Genetics were removed. These are minor navigational and metadata changes that do not affect the study details or primary information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T08:23:31.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' to related topics and included a MedlinePlus Genetics link in the related topics section.
    Difference
    0.1%
    Check dated 2025-12-08T20:24:26.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.3.2; removed 'Multiple Myeloma' and related topics (MedlinePlus Genetics) from the page's topics list.
    Difference
    0.2%
    Check dated 2025-12-01T16:41:48.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added related topics: Multiple Myeloma and MedlinePlus Genetics. Updated the site revision from v3.2.0 to v3.3.1.
    Difference
    0.2%
    Check dated 2025-11-24T13:15:42.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice and related topic links (Multiple Myeloma and MedlinePlus Genetics) from the page, and these changes do not affect the study details; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:27:08.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The new page shows minor formatting/layout tweaks and updated timestamps, while core study information (eligibility criteria, locations, and outcomes) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:07:43.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in Resistant Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.